A Phase 1 Study to Evaluate the Relative Bioavailability of Octreotide Acetate Tablets(T25) Compared to MYCAPSSA® and The Food Effect on Pharmacokinetics Of Octreotide Acetate Tablets(T25)
Clinical trial NCT07663318 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07663318
- Sponsor
- Triastek (Shanghai) Limited
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-26
- Primary completion
- 2026-07-10
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.